Tracy Tang is the founder of Vivace Therapeutics. Vivace Therapeutics has raised $105M in total funding. Latest round: Series D.
Tracy Tang, Ph.D., serves as the head of biology at Vivace Therapeutics. Prior to joining Vivace, she was a senior scientist in translational medicine at OncoMed Pharmaceuticals, where she led and managed many aspects of the company’s clinical biomarker operations. She began her career at Genentech, where she managed several large-scale research projects, including the cancer genome project and collaborations with Lexicon Pharmaceuticals and Curis. She is also a co-inventor on three patents.
Full founder directory · Investor directory · Company funding database · Fundraising library